Summary:
A 37-year-old Japanese man with systemic hemochromatosis due to multiple transfusions was referred to us for the treatment of severe aplastic anemia (SAA), from which he had been suffering for 24 years. The patient had diabetes arising from the hemochromatosis, chronic anal fissures, and a kidney abscess due to neutropenia. He was treated with a nonmyeloablative preconditioning regimen followed by non-T-cell-depleted (non-TCD) allogeneic peripheral blood stem cell transplantation (PBSCT) from his human leukocyte antigen (HLA)-haploidentical 2-loci-mismatched sibling. Prompt engraftment of granulocytes and platelets was observed, and graft-versus-host disease was easy to control. Noninherited maternal antigens in the donor were confirmed prior to PBSCT, and they were also detected in small quantities in the recipient. This report describes the first successful nonmyeloablative hematopoietic stem cell transplant in a heavily transfused SAA patient from an HLA-haploidentical 2-loci-mismatched sibling donor. The result suggests that a long-term fetomaternal microchimerism-positive sibling can be a second-line donor if an alternative HLA-identical donor is not available.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China
Scientific Reports Open Access 06 February 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout


References
Wagner JL, Deeg HJ, Seidel K et al. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives: an update of the Seattle experience. Transplantation 1996; 61: 54–61.
Bacigalupo A, Schrezenmeier H, Hows J et al. Treatment of acquired severe aplastic anemia for the EBMT Working Party on SAA. Int J Pediatr Hematol Oncol 1997; 4: 267–274.
Deeg HJ, Seidel K, Casper J et al. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood Marrow Transplant 1999; 5: 243–252.
Bacigalupo A, Bland R, Oneto R et al. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy – the European Group for Blood and Marrow Transplantation experience. Semin Hematol 2000; 37: 69–80.
Ichinohe T, Maruya E, Saji H . Long-term feto-maternal microchimerism: nature's hidden clue for alternative donor hematopoietic cell transplantation? Int J Hematol 2002; 76: 229–237.
van Rood JJ, Loberiza FR, Zang MJ et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrrow transplantation from a parent or an HLA-haploidentical sibling. Blood 2002; 99: 1572–1577.
Tamaki S, Ichinohe T, Matsuo K et al. Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts. Bone Marrow Transplant 2001; 28: 375–380.
Shimazaki C, Ochiai N, Uchida R et al. Non-T-cell depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal microchimerism. Blood 2003; 101: 3334–3336.
Tzeng CH, Hsieh RK, Fan S et al. Bone marrow transplantation for severe aplastic anemia – a study of twenty-one Chinese patients in Taiwan. Transplantation 1992; 53: 569–574.
Sondel PM, Bozdech MJ, Trigg ME et al. Additional immunosuppression allows engraftment following HLA-mismatched T-cell-depleted bone marrow transplantation for leukemia. Trans Proc 1985; XVII: 462–464.
Ochiai N, Shimazaki C, Fuchida S et al. Successful non-T cell-depleted HLA haplo-identical three loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia. Bone Marrow Transplant 2002; 30: 793–796.
Uoshima N, Kamitsuji Y, Maruya E, Saji H . Successful reduced-intensity stem cell transplantation from an HLA haploidentical 3-loci-mismatched donor on the basis of feto-maternal microchimerism in a patient with advanced acute myeloid leukemia. Int J Hematol 2003; 78: 69–72.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsutsumi, Y., Tanaka, J., Miura, T. et al. Successful non-T-cell-depleted nonmyeloablative hematopoietic stem cell transplantation (NST) from an HLA-haploidentical 2-loci-mismatched sibling in a heavily transfused patient with severe aplastic anemia based on the fetomaternal microchimerism. Bone Marrow Transplant 34, 267–269 (2004). https://doi.org/10.1038/sj.bmt.1704567
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704567
Keywords
- nonmyeloablative stem cell transplantation (NST)
- HLA 2-loci-mismatched donor
- noninherited maternal antigen (NIMA)
- fetomaternal microchimerism
- severe aplastic anemia (SAA)
This article is cited by
-
Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China
Scientific Reports (2018)
-
Incognito: Are Microchimeric Fetal Stem Cells that Cross Placental Barrier Real Emissaries of Peace?
Stem Cell Reviews and Reports (2018)
-
Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study
Bone Marrow Transplantation (2015)
-
Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy
Bone Marrow Transplantation (2014)